Twentyeight-Seven Therapeutics competitorsClear all

Twentyeight-Seven Therapeutics's top competitors include Storm Therapeutics, Anavex and Pinteon Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Twentyeight-Seven Therapeutics
Twentyeight-Seven Therapeutics
Twentyeight-Seven Therapeutics is a biotechnology company focused on the modulation of non-coding RNA (ncRNA) function to treat cancer and other human diseases.
Storm Therapeutics
Storm Therapeutics
Storm Therapeutics discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer.
Anavex
Anavex
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
Pinteon Therapeutics
Pinteon Therapeutics
Pinteon Therapeutics is a company that develops cancer therapeutics drugs intended to cure cis-trans isomerase.
Founding Date
Founding Date
2016
Founding Date
2015
Founding Date
2006
Founding Date
2014
Type
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Watertown, US HQ
Locations
Cambridge, GB HQ
Greater London, GB
Locations
New York, US HQ
Reno, US
Locations
HQ
Employees
Employees
176% decrease
Employees
26
Employees
1623% increase
Employees
8
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.5 k
Twitter followers
38
Alexa Website Rank
Alexa Website Rank
471003
Alexa Website Rank
289632
Alexa Website Rank
182345
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
$ 15m (over 2 years ago)
Latest funding round
$ 5.4m (almost 4 years ago)
Latest funding round
N/A
Latest funding round
$ 17m (about 2 years ago)
Total funding raised
Total funding raised
$ 80m
Total funding raised
$ 21.4m
Total funding raised
$ 12.6m
Total funding raised
$ 20.5m
For sources of this data, please see the company profile

View company profiles

Storm Therapeutics
HQ
Cambridge, GB
Employees
26

Storm Therapeutics discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer.

View company
Anavex
HQ
New York, US
Employees
16↑ 23% increase

Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.

View company
Pinteon Therapeutics
HQ
Employees
8

Pinteon Therapeutics is a company that develops cancer therapeutics drugs intended to cure cis-trans isomerase.

View company